Skip to main content
TipRanks
Go Ultimate75% OFF

Jula Inrig Insider Profile

4 Followers

Jula Inrig, EVP, Head of R&D & CMO at Travere Therapeutics, holds 100.49K shares in Travere Therapeutics (Ticker: TVTX).

Jula Inrig's Trading History

TVTX
Travere Therapeutics
Sep 17, 2026EVP, Head of R&D & CMOUninformative Buy289.29K$5.09M
TVTX
Insider Shares: 100.49K (0.11%)

Jula Inrig has not reported any informative transactions for TVTX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 17, 2026Uninformative Sell$2.78M44,674$62.33―
Sep 17, 2026Uninformative Buy$289.29K32,395$8.93―
Jun 22, 2026Uninformative Sell$0.00468$0.00―
May 06, 2026Uninformative Sell$900.00K20,000$45.00―
May 06, 2026Uninformative Buy$487.54K21,765$22.40―

You May Also Like

Jula Inrig insider profile FAQ

What stocks does Jula Inrig hold?
Jula Inrig holds: TVTX stocks.
What was Jula Inrig’s latest transaction?
Jula Inrig’s latest transaction was an Uninformative Buy of $289.29K.
What is Jula Inrig's role in Travere Therapeutics?
Jula Inrig's role in Travere Therapeutics is EVP, Head of R&D & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.